BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Mallinckrodt Pharmaceuticals 

675 McDonnell Boulevard

Hazelwood  Missouri  63042  U.S.A.
Phone: 314-654-2000 Fax: 314-654-5381


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Medical Device


Collaborations

Advanced Magnetics, Inc.  GastroMARK in North America





 Company News
Mallinckrodt Pharmaceuticals (MNK) Scoops Up Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) For About $5.6 Billion 4/7/2014 9:56:09 AM    More...
Mallinckrodt Pharmaceuticals (MNK) And Verde Environmental Technologies, Inc., Team To Provide Medsaway Medication Disposal System 4/3/2014 9:37:08 AM    More...
Mallinckrodt Pharmaceuticals (MNK) Completes $1.4 Billion Acquisition Of Cadence Pharmaceuticals, Inc. 3/19/2014 10:07:58 AM    More...
Mallinckrodt Pharmaceuticals (MNK) Receives FDA Approval For XARTEMIS XR (Oxycodone Hydrochloride And Acetaminophen) Extended-Release Tablets (CII) 3/12/2014 6:58:38 AM    More...
Mallinckrodt Pharmaceuticals (MNK) To Present At Barclays Global Healthcare Conference 2/28/2014 7:52:11 AM    More...
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 2/25/2014 9:50:28 AM    More...
Mallinckrodt Pharmaceuticals (MNK) Adds Pain Drug With $1.3 Billion Cash Cadence Pharmaceuticals, Inc. Buyout 2/11/2014 7:08:21 AM    More...
Mallinckrodt Pharmaceuticals (MNK)’ New Drug Available To Patients 2/10/2014 10:14:33 AM    More...
Nuvo Research Inc. (NRI.TO) Announces The U.S. Commercial Launch Of PENNSAID® 2% By Mallinckrodt Pharmaceuticals (MNK) 2/10/2014 10:10:18 AM    More...
Mallinckrodt Pharmaceuticals (MNK) To Present At Leerink Swann and Company Global Healthcare Conference 2/5/2014 8:31:57 AM    More...
12345678